Kristin Zwanch Ma, Jd

Kristin Zwanch, MA, JD, currently serves as the Senior Key Account Manager at Adaptive Biotechnologies Corp., focusing on market development for clonoSEQ, a next-gen sequencing diagnostic assay. Responsibilities include account strategy, institutional contracting, KOL engagement, and commercial training. Prior experience includes positions at Bayer as an Oncology Specialty Consultant, leading the launch of significant oncology products, and Acorda Therapeutics, where Kristin held dual roles, overseeing training and business management. Additional roles were held at UCB, Gilead Sciences, and Genentech, with a focus on various therapeutic areas, including oncology, infectious disease, and immunology. Kristin holds a JD from the University of Arizona and an MA in Research and Experimental Psychology from Southern Methodist University.